Angi Inc.
ANGI Nasdaq Services-Advertising Financials FY2016–FY2025
Last close · Oct 23, 2026
$6.62
1.6%What Angi Inc. does
No business description yet.
- Legal name
- Angi Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 20, 2026
- Accession · CIK
- 0001705110-26-000011
0001705110
Revenue and margins
Angi Inc. had $1.0B of revenue in fiscal 2025, down 13.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 46.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $45.5M in fiscal 2025, 4.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Angi Inc. returned — to shareholders in fiscal 2025. The diluted share count fell 8.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Angi Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $428M | $321M | $364M | $416M | $304M |
| Debt incl. finance leases | $495M | $495M | $496M | $497M | $498M |
| Net debt / EBITDA | — | 91.5x | 2.0x | 0.7x | 1.8x |
| Debt / equity | 0.4x | 0.5x | 0.5x | 0.5x | 0.5x |
| Interest coverage | −2.9x | −3.8x | −1.3x | 1.1x | 3.2x |
| Current ratio | 2.1x | 1.7x | 1.9x | 2.1x | 1.6x |
| Quick ratio | 2.1x | 1.7x | 1.9x | 2.1x | 1.6x |
| Total assets | $2.0B | $1.9B | $1.9B | $1.8B | $1.7B |
| Total liabilities | $877M | $859M | $815M | $768M | $753M |
| Shareholders' equity | $1.1B | $1.0B | $1.0B | $1.1B | $927M |
| Net debt (− = net cash) | $66.4M | $174M | $132M | $80.4M | $194M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ |
| Current ratio rose | — | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ | ✓ |
| Gross margin rose | — | ✓ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ |
| F-score | — / 3 | 4 / 9 | 7 / 9 | 6 / 9 | 4 / 9 | 4 / 9 | 3 / 9 | 6 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | −11.8% | −16.4% | −8.9% | −9.6% | −9.1% | −3.5% | −7.9% | −7.1% | −6.5% | −3.5% |
| Altman Z'' | 1.59 | 1.66 | 3.98 | 3.41 | 3.28 | 2.03 | 1.39 | 1.65 | 2.13 | 1.82 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $499M | $736M | $1.1B | $1.3B | $1.5B | $1.6B | $1.8B | $1.4B | $1.2B | $1.0B |
| Provision for credit losses | $17.4M | $27.5M | $47.2M | $64.3M | — | — | — | — | — | — |
| Gross profit | $473M | $702M | $1.1B | $1.3B | $1.3B | $1.3B | $1.4B | $1.3B | $1.1B | $983M |
| Research and development | $20.6M | $47.9M | $61.1M | $64.2M | $68.8M | $70.9M | $73.8M | $96.5M | $95.4M | $87.4M |
| Operating income | $24.1M | −$148M | $63.9M | $38.6M | −$6.4M | −$67.9M | −$75.6M | −$26.5M | $21.9M | $65.4M |
| Interest expense | $0.0M | $1.8M | $11.6M | $11.5M | $14.2M | $23.5M | $20.1M | $20.1M | $20.2M | $20.5M |
| Pretax income | $22.5M | −$154M | $70.0M | $33.6M | −$19.3M | −$93.9M | −$94.6M | −$28.2M | $20.1M | $62.5M |
| Income tax | $11.8M | −$49.1M | −$7.5M | −$1.7M | −$15.2M | −$29.9M | −$5.4M | $1.8M | −$16.8M | $18.7M |
| Net income | $13.1M | −$103M | $77.5M | $34.8M | −$6.3M | −$70.5M | −$128M | −$40.3M | $36.8M | $43.8M |
| Net income to common | $13.1M | −$103M | $77.3M | $34.8M | −$6.3M | −$71.4M | −$128M | −$40.9M | $36.0M | $43.8M |
| Diluted EPS | $0.03 | −$0.24 | $0.15 | $0.07 | −$0.01 | −$0.14 | −$0.26 | −$0.81 | $0.71 | $0.94 |
| Diluted shares | 0.41B | 0.43B | 0.51B | 0.52B | 0.50B | 0.50B | 0.50B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $47.9M | $41.8M | $224M | $214M | $188M | $6.2M | $27.1M | $94.2M | $156M | $105M |
| Capital expenditure | $16.7M | $26.8M | $47.0M | $68.8M | $52.5M | $69.9M | $115M | $47.8M | $50.5M | $59.6M |
| Free cash flow | $31.2M | $15.0M | $177M | $145M | $136M | −$63.7M | −$88.4M | $46.4M | $105M | $45.5M |
| Depreciation and amortization | $8.4M | $14.5M | $24.3M | $39.9M | $52.6M | $59.0M | $77.5M | $93.6M | $86.1M | $45.3M |
| Stock-based compensation | $8.9M | $149M | $97.1M | $68.3M | $83.6M | $28.2M | $50.8M | $43.4M | $34.8M | $14.8M |
| Acquisitions | $15.6M | $66.3M | −$3.7M | $20.3M | $2.3M | $25.6M | $0.0M | — | — | — |
| Balance sheet | ||||||||||
| Cash and short-term investments | $36.4M | $222M | $362M | $391M | $863M | $428M | $321M | $364M | $416M | $304M |
| Total debt | $0.0M | $275M | $261M | $248M | $712M | $495M | $495M | $496M | $497M | $498M |
| Current assets | $63.8M | $262M | $474M | $500M | $978M | $585M | $484M | $487M | $495M | $366M |
| Current liabilities | $67.6M | $171M | $201M | $215M | $234M | $278M | $282M | $259M | $232M | $222M |
| Property and equipment, net | $23.6M | $53.3M | $70.9M | $103M | $109M | $118M | $153M | $110M | $79.6M | $99.1M |
| Goodwill | $171M | $770M | $895M | $884M | $892M | $916M | $883M | $886M | $883M | $890M |
| Intangible assets | $10.8M | $329M | $304M | $252M | $210M | $194M | $178M | $171M | $168M | $167M |
| Total assets | $296M | $1.5B | $1.8B | $1.9B | $2.4B | $2.0B | $1.9B | $1.9B | $1.8B | $1.7B |
| Total liabilities | $142M | $474M | $495M | $607M | $1.1B | $877M | $859M | $815M | $768M | $753M |
| Shareholders' equity | $153M | $993M | $1.3B | $1.3B | $1.3B | $1.1B | $1.0B | $1.0B | $1.1B | $927M |
| Margins | ||||||||||
| Gross margin | 94.8% | 95.4% | 95.1% | 96.5% | 88.2% | 83.0% | 80.9% | 95.4% | 95.1% | 95.4% |
| Operating margin | 4.8% | −20.1% | 5.6% | 2.9% | −0.4% | −4.2% | −4.3% | −2.0% | 1.8% | 6.3% |
| EBITDA margin | 6.5% | −18.1% | 7.8% | 5.9% | 3.2% | −0.5% | 0.1% | 4.9% | 9.1% | 10.7% |
| Net margin | 2.6% | −14.0% | 6.8% | 2.6% | −0.4% | −4.4% | −7.3% | −3.0% | 3.1% | 4.3% |
| FCF margin | 6.3% | 2.0% | 15.6% | 11.0% | 9.3% | −3.9% | −5.0% | 3.4% | 8.9% | 4.4% |
| Returns | ||||||||||
| Return on capital | 13.4% | −11.2% | 5.3% | 3.3% | −0.4% | −4.5% | −4.9% | −1.8% | 1.9% | 4.1% |
| Return on capital employed | 10.6% | −11.4% | 4.0% | 2.3% | −0.3% | −3.9% | −4.7% | −1.7% | 1.4% | 4.5% |
| Return on equity | 8.6% | −18.0% | 6.7% | 2.7% | −0.5% | −5.9% | −11.7% | −3.9% | 3.5% | 4.4% |
| Return on assets | 4.4% | −11.7% | 4.7% | 1.9% | −0.3% | −3.2% | −6.5% | −2.1% | 2.0% | 2.5% |
| Return on tangible equity | — | — | 67.9% | 19.5% | −3.7% | −288.3% | — | — | 307.8% | — |
| Growth | ||||||||||
| Revenue growth | — | 47.6% | 53.8% | 17.1% | 10.7% | 10.3% | 9.0% | −23.0% | −12.8% | −13.0% |
| Net income growth | — | −885.5% | — | −55.1% | −118.0% | — | — | — | — | 19.0% |
| EPS growth | — | −900.0% | — | −53.3% | −114.3% | — | — | — | — | 32.4% |
| FCF growth | — | −52.0% | 1,079.3% | −17.7% | −6.5% | −146.9% | — | — | 127.2% | −56.9% |
| Share count change | — | 3.8% | 19.3% | 0.8% | −3.8% | 0.9% | 0.0% | −89.9% | 0.2% | −8.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | −1.1x | — | −1.1x | −1.8x | −3.3x | — | 91.5x | 2.0x | 0.7x | 1.8x |
| Debt / equity | 0.0x | 0.3x | 0.2x | 0.2x | 0.6x | 0.4x | 0.5x | 0.5x | 0.5x | 0.5x |
| Interest coverage | — | −83.8x | 5.5x | 3.4x | −0.4x | −2.9x | −3.8x | −1.3x | 1.1x | 3.2x |
| Current ratio | 0.9x | 1.5x | 2.4x | 2.3x | 4.2x | 2.1x | 1.7x | 1.9x | 2.1x | 1.6x |
| Quick ratio | 0.9x | 1.5x | 2.4x | 2.3x | 4.2x | 2.1x | 1.7x | 1.9x | 2.1x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.3% | 3.6% | 4.1% | 5.2% | 3.6% | 4.3% | 6.5% | 3.5% | 4.3% | 5.8% |
| Stock comp / revenue | 1.8% | 20.3% | 8.6% | 5.1% | 5.7% | 1.7% | 2.9% | 3.2% | 2.9% | 1.4% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 4.0 | 7.0 | 6.0 | 4.0 | 4.0 | 3.0 | 6.0 | 5.0 | 6.0 |
| Altman Z'' | 1.6 | 1.7 | 4.0 | 3.4 | 3.3 | 2.0 | 1.4 | 1.6 | 2.1 | 1.8 |
| Accruals ratio | −11.8% | −16.4% | −8.9% | −9.6% | −9.1% | −3.5% | −7.9% | −7.1% | −6.5% | −3.5% |
Source: SEC EDGAR XBRL filings (CIK 0001705110). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
